EFFICIENCY OF ANTI-INFLAMMATORY THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS ACCORDING TO THE RESULTS OF A PROSPECTIVE FOLLOW-UP STUDY

In accordance with the Ankylosing Spondylitis Assessments (ASAS) International Working Group guidelines, tumor necrosis factor-α inhibitors are recommended in patients with ankylosing spondylitis (AS) refractory to at least two nonsteroidal anti-inflammatory drugs (NSAIDs) and in those with the...

Full description

Bibliographic Details
Published in:	Научно-практическая ревматология
Main Authors:	T. A. Raskina, O. S. Malyshenko, O. A. Pirogova, M. A. Volykova
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2016-09-01
Subjects:	ankylosing spondylitis men nonsteroidal anti-inflammatory drugs infliximab
Online Access:	https://rsp.mediar-press.net/rsp/article/view/2253

Similar Items

Choice of a nonsteroidal anti-inflammatory drug in ankylosing spondylitis
by: Rimma Mikhailovna Balabanova, et al.
Published: (2014-12-01)

Nonsteroidal anti-inflammatory drugs: a basis for the treatment of ankylosing spondylitis
by: A A Godzenko
Published: (2011-12-01)

Comparative efficacy of infliximab and adalimumab in patients with ankylosing spondylitis
by: Tatyana Valentinovna Mezenova, et al.
Published: (2012-04-01)

EFFECTS OF ANTI-INFLAMMATORY THERAPY ON BONE MINERAL DENSITY IN PATIENTS WITH ANKYLOSING SPONDYLITIS: RESULTS OF PROSPECTIVE STUDY
by: Tatiana A. Raskina, et al.
Published: (2016-03-01)

Musculoskeletal losses in patients with ankylosing spondylitis
by: T. A. Raskina, et al.
Published: (2019-10-01)

Treatment of ankylosing spondylitis during pregnancy
by: O. A. Krichevskaya, et al.
Published: (2021-07-01)

OSTEOPOROSIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: TATIANA A. Raskina, et al.
Published: (2019-03-01)

Prospects for the use of celecoxib in patients with ankylosing spondylitis: impact on retarding disease progression
by: Yulia Leonidovna Korsakova
Published: (2012-09-01)

ATTEMPT OF OVERCOMING SECONDARY INEFFECTIVENESS OF INFLIXIMAB IN A PATIENT WITH ANKYLOSING SPONDYLITIS USING PLASMAPHERESIS (A CASE REPORT)
by: Oksana Alekseyevna Rumyantseva, et al.
Published: (2014-02-01)

Experience with long-term infliximab therapy in patients with ankylosing spondylitis
by: Oksana Alekseevna Rumyantseva, et al.
Published: (2010-12-01)

Problems of prescribing nonsteroidal anti-inflammatory drugs for reproductive-aged women with ankylosing spondylitis
by: O. A. Krichevskaya, et al.
Published: (2020-09-01)

Non-Steroidal Anti-Inflammatory Drug Etoricoxib Facilitates the Application of Individualized Exercise Programs in Patients with Ankylosing Spondylitis
by: Iulia Rahela Marcu, et al.
Published: (2020-05-01)

THE THYROID GLAND STATUS IN PATIENTS WITH ANKYLOSING SPONDYLITIS DURING STANDARD THERAPY AND BIOLOGICAL THERAPY
by: G. R. Akhunova, et al.
Published: (2014-07-01)

Indicators of the osteoclastogenesis system in men with different clinical types of ankylosing spondylitis
by: T. A. Raskina, et al.
Published: (2015-06-01)

Comparative efficacy and safety of infliximab biosimilar (BCD-055) and innovator infliximab in patients with ankylosing spondylitis (results of international, multiple-center, double-blind phase I and phase III clinical studies)
by: D. E. Karateev, et al.
Published: (2017-09-01)

COMPARATIVE EVALUATION OF THE LONG-TERM EFFICACY AND SAFETY OF THE INFLIXIMAB BIOSIMILAR BCD-055 AND REFERENCE INFLIXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS: RESULTS OF THE INTERNATIONAL MULTICENTER RANDOMIZED DOUBLE-BLIND PHASE III CLINICAL STUDY ASART-2
by: A. M. Lila, et al.
Published: (2018-07-01)

Spine inflammatory changes in patients with ankylosing spondylitis assessed by magnetic resonance image
by: A G Bochkova, et al.
Published: (2008-10-01)

Infliximab-induced retrobulbar optic neuritis in a patient with ankylosing spondylitis
by: Dündar, Sema, et al.
Published: (2023-12-01)

USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS, MONITORING THEIR EFFICACY AND SAFETY (DRAFT GUIDELINES OF THE EXPERT SPONDYLOARTHRITIS DIAGNOSIS AND TREATMENT GROUP)
by: I. Z. Gaidukova, et al.
Published: (2016-09-01)

Extraskeletal manifestations and the indicators of inflammatory activity and severity in ankylosing spondylitis
by: A. A. Godzenko, et al.
Published: (2018-04-01)

Comparison between Reference Infliximab (Remicade) and its Biosimilar (Remsima) in Patients with Ankylosing Spondylitis: A Field-based Pharmacoeconomic Study
by: Hasan Raid Fadhil, et al.
Published: (2023-04-01)

TREATMENT IN PATIENTS WITH ANKYLOSING SPONDYLITIS IN THE REAL CLINICAL PRACTICE OF A RHEUMATOLOGIST IN RUSSIA
by: Sh F Erdes, et al.
Published: (2013-02-01)

Effect of infliximab on quality of life in patients with ankylosing spondylitis according to sf-36 questionnaire data
by: Tatyana Alekseevna Raskina, et al.
Published: (2013-10-01)

Effect of HLA-B27 status and body mass index on the clinical response to infliximab in ankylosing spondylitis patients
by: Mohammed Hadi Al-Osami, et al.
Published: (2018-01-01)

Ankylosing Spondylitis
by: Nazanin Ebrahimiadib, et al.
Published: (2021-07-01)

OSTEOPOROSIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Elena Efimovna Gubar, et al.
Published: (2013-12-01)

Coxitis in patients with ankylosing spondylitis: clinicoradio logic comparisons
by: A. G. Bochkova, et al.
Published: (2005-08-01)

COURSE OF UVEITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: A. A. Godzenko, et al.
Published: (2016-09-01)

EXPERIENCE WITH RITUXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Mikhail Sergeyevich Protopopov, et al.
Published: (2013-02-01)

Symptomatic therapy for ankylosing spondylitis
by: Vladimir Vasilyevich Badokin
Published: (2012-03-01)

THE FREQUENCY AND SEVERITY OF EXTRASKELETAL MANIFESTATIONS OF ANKYLOSING SPONDYLITIS
by: A. A. Godzenko, et al.
Published: (2017-04-01)

Vessel wall stiffness in ankylosing spondylitis patients taking nonsteroidal anti-inflammatory drugs
by: I. Z. Gaidukova, et al.
Published: (2016-09-01)

Evaluation of efficacy and safety of long-term use of amtolmetin guacil in rheumatic diseases: results of a 9-month observational AURORA study (Amtolmetin guacil: allRussian Register for Osteoarthritis, Rheumatoid arthritis and Ankylosing spondylitis)
by: A. E. Karateev, et al.
Published: (2019-03-01)

Features of ankylosing spondylitis at different stages in men and women
by: I. A. Cherentsova, et al.
Published: (2019-05-01)

SIGNIFICANCE OF PERIPHERAL ARTHRITIS IN ANKYLOSING SPONDYLITIS
by: Sh. F. Erdes, et al.
Published: (2014-06-01)

Patients with Ankylosing Spondylitis Can Maintain Clinical and Functional Improvement after Switching from Infliximab Reference Product to Infliximab Biosimilar (REMSIMA): 12 Months Comparative Open-Label Study
by: Abdulsatar J. Mathkhor, et al.
Published: (2022-12-01)

Ankylosing spondylitis with concurrent Takayasu arteritis: a clinical case report
by: O. B. Nesmeyanova, et al.
Published: (2019-10-01)

Factors associated with anti-drug antibody production in ankylosing spondylitis patients treated with the infliximab biosimilar CT-P13
by: Yongbum Kim, et al.
Published: (2025-04-01)

A rare case report: Myopathy related to the interaction between azathioprine and infliximab in the treatment of ulcerative colitis and ankylosing spondylitis
by: Lingyu Fu, et al.
Published: (2024-06-01)

Symptom modifiers in therapy for ankylosing spondylitis
by: V. V. Badokin
Published: (2010-06-01)